Kelly Bleasby

1.6k total citations
21 papers, 1.1k citations indexed

About

Kelly Bleasby is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Kelly Bleasby has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 3 papers in Infectious Diseases. Recurrent topics in Kelly Bleasby's work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Adenosine and Purinergic Signaling (3 papers). Kelly Bleasby is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Adenosine and Purinergic Signaling (3 papers). Kelly Bleasby collaborates with scholars based in United States, United Kingdom and Canada. Kelly Bleasby's co-authors include Raymond Evers, Xiaoyan Chu, Colin Brown, Irene Nunes, John B. Pritchard, Jennifer L. Perry, Harvey W. Mohrenweiser, Michael J. Hafey, C. J. Roberts and John C. Castle and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Kelly Bleasby

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly Bleasby United States	16	674	349	240	236	165	21	1.1k
Annick Seithel Germany	6	765 1.1×	371 1.1×	214 0.9×	251 1.1×	132 0.8×	7	1.1k
Gustav Ahlin Sweden	7	813 1.2×	389 1.1×	265 1.1×	245 1.0×	141 0.9×	8	1.1k
Annikka Kalliokoski Finland	9	710 1.1×	396 1.1×	203 0.8×	423 1.8×	139 0.8×	12	1.2k
Mitchell E. Taub United States	19	908 1.3×	464 1.3×	354 1.5×	390 1.7×	139 0.8×	51	1.4k
Yoshitane Nozaki Japan	16	902 1.3×	497 1.4×	193 0.8×	336 1.4×	134 0.8×	26	1.3k
Masaya Itoda Japan	13	657 1.0×	296 0.8×	249 1.0×	290 1.2×	137 0.8×	17	945
Suparat Khamdang Japan	10	749 1.1×	388 1.1×	283 1.2×	183 0.8×	110 0.7×	12	1.4k
Xiaoxin Cai United States	14	578 0.9×	340 1.0×	155 0.6×	388 1.6×	123 0.7×	16	1.0k
Amanda Obaidat United States	5	645 1.0×	260 0.7×	263 1.1×	171 0.7×	84 0.5×	5	1.0k
Masayuki Tsujimoto Japan	19	623 0.9×	316 0.9×	289 1.2×	338 1.4×	63 0.4×	76	1.3k

Countries citing papers authored by Kelly Bleasby

Since Specialization

Citations

This map shows the geographic impact of Kelly Bleasby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Bleasby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Bleasby more than expected).

Fields of papers citing papers by Kelly Bleasby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Bleasby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Bleasby. The network helps show where Kelly Bleasby may publish in the future.

Co-authorship network of co-authors of Kelly Bleasby

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Bleasby. A scholar is included among the top collaborators of Kelly Bleasby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Bleasby. Kelly Bleasby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bleasby, Kelly, Robert Houle, Michael J. Hafey, et al.. (2021). Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. Viruses. 13(8). 1566–1566. 17 indexed citations

Bleasby, Kelly, Kerry L. Fillgrove, Robert Houle, et al.. (2019). In Vitro Evaluation of the Drug Interaction Potential of Doravirine. Antimicrobial Agents and Chemotherapy. 63(4). 23 indexed citations

Chu, Xiaoyan, Kelly Bleasby, Gordon Chan, Irene Nunes, & Raymond Evers. (2016). The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?. Drug Metabolism and Disposition. 44(9). 1498–1509. 85 indexed citations

Chu, Xiaoyan, et al.. (2016). Transporters affecting biochemical test results: Creatinine‐drug interactions. Clinical Pharmacology & Therapeutics. 100(5). 437–440. 30 indexed citations

Sherer, Edward C., Andreas Verras, Maria Madeira, et al.. (2012). QSAR Prediction of Passive Permeability in the LLC‐PK1 Cell Line: Trends in Molecular Properties and Cross‐Prediction of Caco‐2 Permeabilities. Molecular Informatics. 31(3-4). 231–245. 28 indexed citations

Wu, Zhicai, Thomas H. Graham, Andreas Verras, et al.. (2012). Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(4). 1727–1730. 4 indexed citations

Chu, Xiaoyan, Kelly Bleasby, & Raymond Evers. (2012). Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opinion on Drug Metabolism & Toxicology. 9(3). 237–252. 227 indexed citations

Lévesque, Jean-François, Kelly Bleasby, Amandine Chefson, et al.. (2011). Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5547–5551. 9 indexed citations

Powell, David, W. Cameron Black, Kelly Bleasby, et al.. (2011). Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7281–7286. 15 indexed citations

10.

Monteagudo, Edith, Massimiliano Fonsi, Xiaoyan Chu, et al.. (2010). The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease. Xenobiotica. 40(12). 826–839. 12 indexed citations

11.

He, Huaibing, Kathryn A. Lyons, Xiaofang Shen, et al.. (2009). Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure. Xenobiotica. 39(9). 687–693. 18 indexed citations

12.

Weinglass, Adam B., Martin Köhler, Jessica Liu, et al.. (2008). Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol Uptake. Molecular Pharmacology. 73(4). 1072–1084. 22 indexed citations

13.

Chu, Xiaoyan, Kelly Bleasby, Jocelyn Yabut, et al.. (2007). Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 321(2). 673–683. 143 indexed citations

14.

Bleasby, Kelly, John C. Castle, C. J. Roberts, et al.. (2006). Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition. Xenobiotica. 36(10-11). 963–988. 216 indexed citations

15.

Aslamkhan, Amy G., Deborah Thompson, Jennifer L. Perry, et al.. (2006). The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 291(6). R1773–R1780. 20 indexed citations

16.

Bleasby, Kelly, et al.. (2005). Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6). Journal of Pharmacology and Experimental Therapeutics. 314(2). 923–931. 98 indexed citations

17.

Brown, Colin, et al.. (2001). Rosuvastatin is a high affinity substrate of hepatic organic anion transporter OATP-C. Atherosclerosis Supplements. 2(2). 90–90. 57 indexed citations

18.

Bleasby, Kelly, Seema Chauhan, & Colin Brown. (2000). Characterization of MPP⁺ secretion across human intestinal Caco‐2 cell monolayers: role of P‐glycoprotein and a novel Na⁺‐dependent organic cation transport mechanism. British Journal of Pharmacology. 129(3). 619–625. 28 indexed citations

19.

Bleasby, Kelly, et al.. (2000). The organic cation transporter OCT2 mediates the uptake of β‐adrenoceptor antagonists across the apical membrane of renal LLC‐PK₁ cell monolayers. British Journal of Pharmacology. 131(1). 71–79. 64 indexed citations

20.

Bleasby, Kelly, M A Clark, & Colin Brown. (1999). Functional expression of an epitope tagged version of the human organic cation transporter hOCT2 in mIMCD3 cells. 520. 13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact